Dental caries: prevalence of root caries · Children and adults (aged 16 years or less = children, over 16 = adults) without periodontitis at baseline; in practice mostly adults,…
Triclosan/copolymer-containing fluoride toothpaste probably leads to lower root caries at 36 months (Katz Root Caries Index) compared with fluoride toothpaste without triclosan (moderate certainty).
1 finding from 1 review
Gingival bleeding (various bleeding indices) · Children and adults (aged 16 years or less = children, over 16 = adults) without periodontitis at baseline; in practice mostly adults,…
Triclosan/copolymer-containing fluoride toothpaste probably leads to lower gingival bleeding at 6 to 7 months (Gingivitis Severity Index,… compared with fluoride toothpaste without triclosan (moderate certainty).
2 findings from 1 review
Gingivitis · Children and adults (aged 16 years or less = children, over 16 = adults) without periodontitis at baseline; in practice mostly adults,…
Triclosan/copolymer-containing fluoride toothpaste probably leads to lower gingivitis at 6 to 9 months (Loe-Silness Gingival Index, 0 to 3 scale) compared with fluoride toothpaste without triclosan (moderate certainty).
1 finding from 1 review
Coronal caries increment · Children and adults (aged 16 years or less = children, over 16 = adults) without periodontitis at baseline; in practice mostly adults,…
Triclosan/copolymer-containing fluoride toothpaste showed no clear difference in coronal caries increment at 30 to 36 months (decayed filled teeth,… compared with fluoride toothpaste without triclosan (high certainty).
2 findings from 1 review
Tooth staining/discolouration (adverse effect) · Children and adults (aged 16 years or less = children, over 16 = adults) without periodontitis at baseline; in practice mostly adults,…
Triclosan/copolymer-containing fluoride toothpaste showed no clear difference in adverse effects (tooth staining, Meckel Stain Score, 6 months) compared with fluoride toothpaste without triclosan; GRADE not reported.
1 finding from 1 review
Toluidine blue (visual staining) vs No screening
Outcome not reported · Planned population: general population or high-risk / opportunistic screening groups (no eligible study)
The review found no eligible studies for this question.
1 finding from 1 review
Intervention not reported
At least 50% of maximum pain relief over 4 to 6 hours · Adults with moderate or severe acute postoperative pain
1 finding from 1 review
no estimate extracted
Studies not reported
Very low
Intervention not reported
Participants with at least 1 adverse event · Adults with moderate or severe acute postoperative pain
1 finding from 1 review
no estimate extracted
Studies not reported
Very low
Intervention not reported
Participants with a serious adverse event · Adults with moderate or severe acute postoperative pain
1 finding from 1 review
no estimate extracted
Studies not reported
Very low
Intervention not reported
Deaths · Adults with moderate or severe acute postoperative pain
1 finding from 1 review
no estimate extracted
Studies not reported
Very low
Intervention not reported
Pain: severity score day 1 Scale from: 1 to 5 · patients with tonsillectomy
1 finding from 1 review
Percentage of participants reaching PASI 75 · People with palmoplantar psoriasis
1 finding from 1 review
Withdrawals due to adverse events · People with palmoplantar psoriasis
1 finding from 1 review
Clearance rate · People with palmoplantar psoriasis
NB‐UVB showed no clear difference in clearance rate compared with topical PUVA (low certainty).
1 finding from 1 review
Participant‐rated global improvement · People with chronic plaque or guttate psoriasis
1 finding from 1 review
Percentage of participants reaching PASI 75 · People with chronic plaque or guttate psoriasis
NB‐UVB plus retinoid showed no clear difference in percentage of participants reaching PASI 75 compared with PUVA plus retinoid (low certainty).
1 finding from 1 review
Withdrawals due to adverse events · People with chronic plaque or guttate psoriasis
1 finding from 1 review
Clearance rate · People with chronic plaque or guttate psoriasis
NB‐UVB plus retinoid showed no clear difference in clearance rate compared with PUVA plus retinoid (low certainty).
1 finding from 1 review
Participant‐rated global improvement · people with chronic plaque psoriasis
1 finding from 1 review
Percentage of participants reaching PASI 75 · people with chronic plaque psoriasis
1 finding from 1 review